Bioptically demonstrated Lafora disease without EPM2A mutation: a clinical and neurophysiological study of two sisters

[1]  K. Yamakawa,et al.  Targeted disruption of the Epm2a gene causes formation of Lafora inclusion bodies, neurodegeneration, ataxia, myoclonus epilepsy and impaired behavioral response in mice. , 2002, Human molecular genetics.

[2]  S. Fahn,et al.  A pilot tolerability and efficacy study of levetiracetam in patients with chronic myoclonus , 2001, Neurology.

[3]  S. Dimauro,et al.  Surprises of genetic engineering , 2001, Neurology.

[4]  P. Genton,et al.  Antimyoclonic effect of levetiracetam. , 2000, Epileptic disorders : international epilepsy journal with videotape.

[5]  S. Scherer,et al.  Laforin is a cell membrane and endoplasmic reticulum–associated protein tyrosine phosphatase , 2001, Annals of neurology.

[6]  J. Serratosa,et al.  Mutational spectrum of the EPM2A gene in progressive myoclonus epilepsy of Lafora: high degree of allelic heterogeneity and prevalence of deletions , 2000, European Journal of Human Genetics.

[7]  S. Scherer,et al.  Identification of new and common mutations in the EPM2A gene in Lafora disease , 2000, Neurology.

[8]  S. Scherer,et al.  Genetic locus heterogeneity in Lafora's progressive myoclonus epilepsy , 1999, Annals of neurology.

[9]  S. Scherer,et al.  Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy , 1998, Nature Genetics.

[10]  S. Lamusuo,et al.  Piracetam relieves symptoms in progressive myoclonus epilepsy: a multicentre, randomised, double blind, crossover study comparing the efficacy and safety of three dosages of oral piracetam with placebo , 1998, Journal of neurology, neurosurgery, and psychiatry.

[11]  N. Quinn,et al.  Familial Lafora body disease of late onset: report of four cases in one family and a review of the literature , 1996, Journal of Neurology.

[12]  P. Satishchandra,et al.  Familial Progressive Myoclonus Epilepsy: Clinical and Electrophysiologic Observations , 1995, Epilepsia.

[13]  A. Beydoun,et al.  Longitudinal EEG Studies in a Kindred with Lafora Disease , 1991, Epilepsia.

[14]  S. Tobimatsu,et al.  Pathogenesis of giant somatosensory evoked potentials in progressive myoclonic epilepsy. , 1985, Brain : a journal of neurology.

[15]  S. Carpenter,et al.  Sweat gland duct cells in Lafora disease , 1981, Neurology.

[16]  Gonzalo R. Lafora,et al.  Beitrag zur Histopathologie der myoklonischen Epilepsie , 1911 .

[17]  D. Seo,et al.  Two novel mutations in the EPM2A gene in a Korean patient with Lafora's progressive myoclonus epilepsy , 2003, Journal of Human Genetics.

[18]  A. Beydoun,et al.  Biopsy results in a kindred with Lafora disease. , 1993, Archives of neurology.

[19]  J. Roger.  Progressive myoclonus epilepsies in childhood and adolescence , 1992 .